Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response.
Liu X, George GC, Tsimberidou AM, Naing A, Wheler JJ, Kopetz S, Fu S, Piha-Paul SA, Eng C, Falchook GS, Janku F, Garrett C, Karp D, Kurzrock R, Zinner R, Raghav K, Subbiah V, Hess K, Meric-Bernstam F, Hong DS, Overman MJ.
Liu X, et al. Among authors: falchook gs.
BMC Cancer. 2015 Oct 16;15:713. doi: 10.1186/s12885-015-1701-3.
BMC Cancer. 2015.
PMID: 26474549
Free PMC article.